Immunodominance is the immunological phenomenon in which immune responses are mounted against only a few of the antigenic peptides out of the many produced.[1] That is, despite multiple allelic variations of MHC molecules and multiple peptides presented on antigen presenting cells, the immune response is skewed to only specific combinations of the two.[1] Immunodominance is evident for both antibody-mediated immunity and cell-mediated immunity.[2][3] Epitopes that are not targeted or targeted to a lower degree during an immune response are known as subdominant epitopes.[1][2] The impact of immunodominance is immunodomination, where immunodominant epitopes will curtail immune responses against non-dominant epitopes.[4]
Antigen-presenting cells such as dendritic cells, can have up to six different types of MHC molecules for antigen presentation.[1] There is a potential for generation of hundreds to thousands of different peptides from the proteins of pathogens.[1] Yet, the effector cell population that is reactive against the pathogen is dominated by cells that recognize only a certain class of MHC bound to only certain pathogen-derived peptides presented by that MHC class.[1]
Antigens from a particular pathogen can be of variable immunogenicity, with the antigen that stimulates the strongest response being the immunodominant one. The different levels of immunogenicity amongst antigens forms what is known as dominance hierarchy.[2]
^ abcdefAkram, A.; R. D. Inman (2012). "Immunodominance: A pivotal principle in host response to viral infections". Clinical Immunology. 143 (2): 99–115. doi:10.1016/j.clim.2012.01.015. PMID 22391152.
^ abcFrank, S. A. (2002). Immunology and Evolution of Infectious Disease. Princeton, NJ: Princeton University Press. pp. 73–89.
^Kastenmuller, W.; Gasteiger, G.; Gronau, J. H.; Baier, R.; Ljapoci, R.; Busch, D. H.; Drexler, I. (2007). "Cross-competition of CD8+ T cells shapes the immunodomiance hierarchy during boost vaccination". Journal of Experimental Medicine. 204 (9): 2187–2198. doi:10.1084/jem.20070489. PMC 2118691. PMID 17709425.
^Perrault, C. (2011). Experimental and Applied Immunotherapy. New York, NY: Humana Press. pp. 195–206.
Immunodominance is the immunological phenomenon in which immune responses are mounted against only a few of the antigenic peptides out of the many produced...
Howarth M, Stevenson FK, Elliott T (February 2008). "Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class...
host, encoded in the host's genome, a particular peptide exhibits immunodominance and loads onto MHC class II molecules. These are trafficked to and...
allele differs from person-to-person. Moreover, as a consequence of immunodominance, an individual's CTL response is limited to a few epitopes of a specific...
indicates that in myelin, sulfatide is a glycolipid that possesses immunodominance. Locally, the disruption of myelin due to the infiltration of T cells...
a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting. The Journal of Immunology, 177(5)...